Plainsboro, NJ, United States of America

Hongyan Qi

This inventor holds 22 USPTO granted patents and 6 published patent applications, plus 7 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag, Fmc Corporation. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongyan Qi. Retrieved from https://idiyas.com/inventor/hongyan-qi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 6)

% Patents Active = 50.0

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 8.5

ph-index = 8

Forward Citations = 167(Granted Patents)

Company Filing History:

19 out of 186

Ptc Therapeutics, Inc.

patents

6 out of 181

F. Hoffmann-La Roche Ag

Hoffmann-La Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

Areas of Expertise:

Spinal Muscular Atrophy

Tetrahydrocarbazoles

Angiogenesis Inhibition

Antibacterial Compounds

Insecticidal Derivatives

Cancer Treatment

Carboline Derivatives

VEGF Production

Substituted Tetrahydro Beta-Carbolines

1,4-Disubstituted Benzenes

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11753407 - Compounds for treating spinal muscular atrophy (2023-09-12),

2. 10947231 - Processes for the preparation of substituted tetrahydro beta-carbolines (2021-03-16),

3. 10851101 - Compounds for treating spinal muscular atrophy (2020-12-01),

4. 10501482 - Compounds for treating spinal muscular atrophy (2019-12-10),

5. RE47689 - Compounds for treating spinal muscular atrophy (2019-11-04),

6. 9914722 - Compounds for treating spinal muscular atrophy (2018-03-13),

7. 9879007 - Compounds for treating spinal muscular atrophy (2018-01-30),

8. 9650395 - Antibacterial compounds and methods for use (2017-05-16),

9. 9617268 - Compounds for treating spinal muscular atrophy (2017-04-11),

10. 9586955 - Compounds for treating spinal muscular atrophy (2017-03-07),

11. 9409905 - Antibacterial compounds and methods for use (2016-08-09),

12. 9351964 - Methods for treating cancer and non-neoplastic conditions (2016-05-31),

13. 9271960 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control (2016-03-01),

14. 8946444 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control (2015-02-03),

15. 8940896 - Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis (2015-01-27),

Title: The Innovative Journey of Hongyan Qi

Introduction: Hongyan Qi, a pioneering inventor hailing from Plainsboro, NJ, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Qi's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and sustainable materials.

Career Highlights: With a career spanning over two decades, Hongyan Qi has established herself as a leading figure in the tech industry, holding multiple patents and receiving accolades for her innovative solutions.

Collaborations: Throughout her career, Qi has collaborated with top research institutions, leading companies, and renowned universities to further develop and implement her inventions on a global scale.

Conclusion: Hongyan Qi's relentless pursuit of innovation and her commitment to creating a positive impact on society through her inventions solidify her position as a trailblazer in the world of technology.

Profile summary based on public USPTO records.